PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Conditions
- Cervical Cancer
- HPV-Related Carcinoma
- HPV-Related Malignancy
- Recurrent Cervical Carcinoma
- Metastatic Cervical Cancer
Interventions
- BIOLOGICAL: PRGN-2009 plus Pembrolizumab
Sponsor
Precigen, Inc
Collaborators